Morbid Obesity and Severe Knee Osteoarthritis - Which Should Be Treated First?
Launched by MEMORIAL UNIVERSITY OF NEWFOUNDLAND · Jan 5, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring the best treatment approach for people who are very overweight and suffering from severe knee arthritis. Specifically, it aims to find out whether having weight loss surgery (called sleeve gastrectomy) before knee replacement surgery leads to better results than having knee replacement first. By comparing the two groups of participants—one group will have weight loss surgery first and the other will have knee replacement first—the researchers hope to learn which order of procedures helps improve quality of life and if there are differences in complications.
To participate in this study, individuals need to be between the ages of 65 and 74, have a body mass index (BMI) of 35 or higher, and be on the waiting list for both knee replacement and weight loss surgery. Participants will be randomly assigned to one of the two treatment orders and will fill out questionnaires to assess their quality of life before and after each procedure. The study is not yet recruiting participants, and it aims to gather important information that could help improve treatment strategies for those facing these health challenges.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • BMI \> or = 35, on surgical waitlist for a total knee arthroplasty and laparoscopic sleeve gastrectomy
- Exclusion Criteria:
- • a history of revision surgery, surgery for neoplastic disease, significant mental illness, ASA class \> 3 denoting absence of significant impact of comorbidities, and previous esophagogastric surgery.
About Memorial University Of Newfoundland
Memorial University of Newfoundland is a distinguished academic institution dedicated to advancing healthcare and medical research through innovative clinical trials. As a leading sponsor, the university leverages its extensive resources and expertise to conduct rigorous studies aimed at improving patient outcomes and understanding complex health conditions. Committed to ethical research practices and community engagement, Memorial University fosters collaboration among multidisciplinary teams, ensuring that its clinical trials contribute valuable insights to the field of medicine while enhancing the quality of life for individuals in Newfoundland and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
St. John's, Newfoundland And Labrador, Canada
St. John's, Newfoundland And Labrador, Canada
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported